Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

Telomir Pharmaceuticals / Equity Bottom-Up

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases.</li><li> The company released test results that showed the company's primary treatment, Telomir-1, showed the ability to reverse the suppression of a master tumor suppressor gene that is silenced in many aggressive cancers.</li><li>This continues the exciting preclinical data that should lead to clinical trials in the near future.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company released test results that showed the company's primary treatment, Telomir-1, showed the ability to reverse the suppression of a master tumor suppressor gene that is silenced in many aggressive cancers.This continues the exciting preclinical data that should lead to clinical trials in the near future.

TELO: Preclinical Tests Show Tumor Suppression Ability

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases.</li><li> The company announced preclinical test results that showed Telomir-1 restored mitochondrial function without triggering oxidative stress or cell proliferation in human cells.</li><li>This sets Telomir-1 apart from many other related treatments and opens the door to treating numerous serious conditions.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced preclinical test results that showed Telomir-1 restored mitochondrial function without triggering oxidative stress or cell proliferation in human cells.This sets Telomir-1 apart from many other related treatments and opens the door to treating numerous serious conditions.

TELO: Treatment Indicates Better Treatment for Serious Diseases

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases.</li><li> The company announced preclinical test results that showed Telomir-1 prevented cellular aging in human progeria cell lines.</li><li> This is further evidence that Telomir-1 has the potential to be a game-changing treatment in diseases associated with aging.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced preclinical test results that showed Telomir-1 prevented cellular aging in human progeria cell lines. This is further evidence that Telomir-1 has the potential to be a game-changing treatment in diseases associated with aging.

TELO: Prevention of Cellular Aging in Patients with Progeria Possible

United States

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company focuses on the development and commercialization of telomir 1, a novel treatment that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer. Telomir Pharmaceuticals serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Telomir Pharmaceuticals (TELO US)

TELO: Preclinical Tests Show Tumor Suppression Ability

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company released...

Zacks Small Cap Research

TELO: Treatment Indicates Better Treatment for Serious Diseases

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced...

Zacks Small Cap Research

TELO: Treatment Indicates Better Treatment for Serious Diseases

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced...

Zacks Small Cap Research

TELO: Treatment Indicates Better Treatment for Serious Diseases

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced...

Zacks Small Cap Research

TELO: Prevention of Cellular Aging in Patients with Progeria Possible

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)